These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 7502830
1. Mucosal responsiveness as a determinant of protection mechanisms induced by oral immunization. Clancy R, Pang G, Cripps A. Adv Exp Med Biol; 1995; 371B():1417-22. PubMed ID: 7502830 [No Abstract] [Full Text] [Related]
2. Acute on chronic bronchitis: A model of mucosal immunology. Clancy R, Pang G, Dunkley M, Taylor D, Cripps A. Immunol Cell Biol; 1995 Oct; 73(5):414-7. PubMed ID: 8595918 [Abstract] [Full Text] [Related]
3. Protection induced against acute bronchitis--the use of human and rat models to determine mechanisms of action of oral immunization with Haemophilus influenzae. Clancy RL, Wallace FJ, Cripps AW, Pang GT. Curr Top Microbiol Immunol; 1989 Oct; 146():181-5. PubMed ID: 2786462 [No Abstract] [Full Text] [Related]
4. The paradox of immunization against Haemophilus influenzae-related endobronchitis: protection restricted to ingestion of 'non-adjuvenated' vaccine. Clancy R, Cripps A, Pang G, Yeung S, Murree-Allen K. Adv Exp Med Biol; 1987 Oct; 216B():1759-64. PubMed ID: 3321940 [No Abstract] [Full Text] [Related]
5. A role for intestinal T lymphocytes in bronchus mucosal immunity. Wallace FJ, Cripps AW, Clancy RL, Husband AJ, Witt CS. Immunology; 1991 Sep; 74(1):68-73. PubMed ID: 1937575 [Abstract] [Full Text] [Related]
6. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx. Abe N, Kodama S, Hirano T, Eto M, Suzuki M. Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899 [Abstract] [Full Text] [Related]
9. Collaborative studies in mucosal immunology in Goroka. Clancy R. P N G Med J; 2010 Mar; 53(3-4):122-5. PubMed ID: 23163182 [Abstract] [Full Text] [Related]
14. [Vaccination against Haemophilus influenzae B]. Szabó V, Mészner Z, Gyarmati E, Pataki M, Hajdi G. Orv Hetil; 1996 Nov 10; 137(45):2547-8. PubMed ID: 8999402 [No Abstract] [Full Text] [Related]
15. Vaccines for Moraxella catarrhalis and non-typeable Haemophilus influenzae. McMichael JC, Green BA. Curr Opin Investig Drugs; 2003 Aug 10; 4(8):953-8. PubMed ID: 14508879 [Abstract] [Full Text] [Related]
19. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx. Kodama S, Hirano T, Noda K, Abe N, Suzuki M. Vaccine; 2010 Mar 16; 28(13):2510-6. PubMed ID: 20117272 [Abstract] [Full Text] [Related]
20. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. Bertot GM, Becker PD, Guzmán CA, Grinstein S. J Infect Dis; 2004 Apr 01; 189(7):1304-12. PubMed ID: 15031801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]